ARTICLE | Clinical News
PTC124 regulatory update
April 3, 2006 7:00 AM UTC
FDA granted Fast Track designation to PTC124 to treat Duchenne muscular dystrophy (DMD) due to a nonsense mutation in the dystrophin gene. The small molecule, which facilitates complete translation o...